To say Bayer’s acquisition of Monsanto has not gone smoothly would be a significant understatement. Since Bayer closed the deal, lawsuits regard Monsanto’s “Roundup” have started to gain traction which has lead to the market trying to “price in” Bayer’s glyphosate liability. Roundup’s main active ingredient is glyphosate, an herbicide …

Should you buy Uber or Lyft’s stock following the IPO? Both have caught a lot of attention in the wave of tech IPO’s that have hit the market this spring. Lyft already IPO’d and surged initially, but has since fallen 33%, which in turn hurt Uber’s expected valuation. Uber priced …

Analysis of the recent Beyond Meat IPO (BYND)

Hostess reported Q1’19 EBITDA of $49MM compared to $46MM of consensus and my $45MM estimate. Sales growth was the really strong point with 6.7% growth, beating consensus by 560bps. This is honestly the best news for Hostess stock since the acquisition of Cloverhill. Recall, Hostess bought Cloverhill out of distress …

CorePoint reported Q1’19 EBITDA of $43MM compared to $40MM estimates and $37MM last year. Net/net this was an OK result. Obviously, EBITDA beat expectations. RevPar was up 3% according to the company, which is ahead of their 0-2% growth guidance. Unfortunately,  though, excluding the hurricane-impacted hotels of last year RevPar …

Facebook reported a great Q1’19 and the stock has climbed a wall-of-worry back to the $195 area. However, Facebook stock is still a buy. To recap, investors have been concerned about the list of negative headlines out of Facebook regarding privacy issues. In addition, based on commentary I’ve heard from …

Although the market was a little shaky after the Fed spoke on Wednesday, the S&P500 ended the week flat-to-up thanks to Friday, May 3rd’s rebound. According to the CME website, the odds of a rate cut (or the Fed lowering interest rates) are actually around 47% by Dec 2019 and …

Market Recap for the week ended April 26th, 2019. Facebook and Amazon earnings, S&P valuation, and more Unicorn sightings